Hospital Biz To Benefit From Remote Monitors, Genetic Tests – Health Affairs
This article was originally published in The Gray Sheet
Remote monitoring devices that demonstrate reduced hospital admissions and emergency room visits present a valid case for reimbursement, according to a Health Affairs article
You may also be interested in...
Innovative reimbursement options for healthcare information technology are necessary to advance the market, according to Daniel Mendelson, managing director of The Health Strategies Consultancy
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.